Literature DB >> 25044308

Autophagy: an adaptive metabolic response to stress shaping the antitumor immunity.

Elodie Viry1, Jerome Paggetti1, Joanna Baginska1, Takouhie Mgrditchian1, Guy Berchem1, Etienne Moussay1, Bassam Janji2.   

Abstract

Several environmental-associated stress conditions, including hypoxia, starvation, oxidative stress, fast growth and cell death suppression, modulate both cellular metabolism and autophagy to enable cancer cells to rapidly adapt to environmental stressors, maintain proliferation and evade therapies. It is now widely accepted that autophagy is essential to support cancer cell growth and metabolism and that metabolic reprogramming in cancer can also favor autophagy induction. Therefore, this complex interplay between autophagy and tumor cell metabolism will provide unique opportunities to identify new therapeutic targets. As the regulation of the autophagic activity is related to metabolism, it is important to elucidate the exact molecular mechanism which drives it and the functional consequence of its activation in the context of cancer therapy. In this review, we will summarize the role of autophagy in shaping the cellular response to an abnormal tumor microenvironment and discuss some recent results on the molecular mechanism by which autophagy plays such a role in the context of the anti-tumor immune response. We will also describe how autophagy activation can behave as a double-edged sword, by activating the immune response in some circumstances, and impairing the anti-tumor immunity in others. These findings imply that defining the precise context-specific role for autophagy in cancer is critical to guide autophagy-based therapeutics which are becoming key strategies to overcome tumor resistance to therapies.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagy; Hypoxia; Immune response; Metabolism; Tumor resistance

Mesh:

Year:  2014        PMID: 25044308     DOI: 10.1016/j.bcp.2014.07.006

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  32 in total

Review 1.  Novel and emerging targeted-based cancer therapy agents and methods.

Authors:  Mohammad Hojjat-Farsangi
Journal:  Tumour Biol       Date:  2015-02-09

Review 2.  Function of PM2.5 in the pathogenesis of lung cancer and chronic airway inflammatory diseases.

Authors:  Ruyi Li; Rui Zhou; Jiange Zhang
Journal:  Oncol Lett       Date:  2018-03-26       Impact factor: 2.967

Review 3.  Autophagy and its implication in human oral diseases.

Authors:  Ya-Qin Tan; Jing Zhang; Gang Zhou
Journal:  Autophagy       Date:  2016-10-20       Impact factor: 16.016

Review 4.  Mechanisms regulating immune surveillance of cellular stress in cancer.

Authors:  Ruth Seelige; Stephen Searles; Jack D Bui
Journal:  Cell Mol Life Sci       Date:  2017-07-25       Impact factor: 9.261

5.  Cancer Stem Cells: An Ever-Hiding Foe.

Authors:  Jacek R Wilczyński
Journal:  Exp Suppl       Date:  2022

6.  Autophagy inhibition upregulates CD4+ tumor infiltrating lymphocyte expression via miR-155 regulation and TRAIL activation.

Authors:  Paul Zarogoulidis; Savvas Petanidis; Kalliopi Domvri; Efrosini Kioseoglou; Doxakis Anestakis; Lutz Freitag; Konstantinos Zarogoulidis; Wolfgang Hohenforst-Schmidt; Wilfried Eberhardt
Journal:  Mol Oncol       Date:  2016-09-16       Impact factor: 6.603

7.  Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition.

Authors:  Marco Cordani; Elisa Oppici; Ilaria Dando; Elena Butturini; Elisa Dalla Pozza; Mercedes Nadal-Serrano; Jordi Oliver; Pilar Roca; Sofia Mariotto; Barbara Cellini; Giovanni Blandino; Marta Palmieri; Silvia Di Agostino; Massimo Donadelli
Journal:  Mol Oncol       Date:  2016-04-12       Impact factor: 6.603

Review 8.  Pathophysiological mechanisms of death resistance in colorectal carcinoma.

Authors:  Ching-Ying Huang; Linda Chia-Hui Yu
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 9.  The Role of Pi, Glutamine and the Essential Amino Acids in Modulating the Metabolism in Diabetes and Cancer.

Authors:  Lakshmipathi Vadlakonda; Meera Indracanti; Suresh K Kalangi; B Meher Gayatri; Navya G Naidu; Aramati B M Reddy
Journal:  J Diabetes Metab Disord       Date:  2020-08-19

10.  Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models.

Authors:  Yao-Xin Lin; Yi Wang; Jianxun Ding; Aiping Jiang; Jie Wang; Mian Yu; Sara Blake; Shuaishuai Liu; Charles J Bieberich; Omid C Farokhzad; Lin Mei; Hao Wang; Jinjun Shi
Journal:  Sci Transl Med       Date:  2021-06-23       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.